Verily, Alphabet’s life sciences division, shuttered its medical hardware program and laid off staff on Monday as the company reallocates resources to dominate the AI and data infrastructure sectors.
CEO Stephen Gillett Cites AI Infrastructure as Future Priority
The decision to dissolve the device unit was communicated via a staff memo from CEO Stephen Gillett. While acknowledging Verily’s legacy in engineering sophisticated medical tools, Gillett emphasized that the firm’s trajectory now demands a concentration on high-growth areas like machine learning and data-driven healthcare solutions.
Alphabet’s Relentless Pursuit of AI Efficiency
This restructuring aligns with parent company Alphabet’s broader mandate to slash operational costs while aggressively funding generative AI initiatives. The tech giant has executed several downsizing phases recently, including workforce reductions in its human resources and cloud divisions in February. Additionally, the Platforms & Devices group saw more than 25,000 employees offered voluntary exit packages earlier this spring.
From Mass Layoffs to the Generative AI Boom
Alphabet’s most significant contraction occurred in January 2023, when the corporation eliminated 12,000 positions—roughly 6% of its total headcount—to brace for economic volatility. This period coincided with the meteoric rise of ChatGPT, which reached 100 million users in record time. That shift in the consumer landscape fundamentally recalibrated the industry’s priorities, forcing legacy tech leaders to prioritize AI over hardware experimentation.
